Consolidated Statement Of Cash Flows

Astellas Pharma Inc. - Filing #7577637

Concept As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
As at
2022-03-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
As at
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-10-01 to
2021-12-31
2021-04-01 to
2021-12-31
As at
2021-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
144,839,000,000 JPY
48,405,000,000 JPY
JPY
JPY
144,839,000,000 JPY
JPY
JPY
JPY
JPY
JPY
144,839,000,000 JPY
JPY
132,495,000,000 JPY
JPY
JPY
JPY
JPY
JPY
132,495,000,000 JPY
132,495,000,000 JPY
JPY
JPY
60,885,000,000 JPY
JPY
Impairment losses (reversal of impairment losses)
24,237,000,000 JPY
26,718,000,000 JPY
Decrease (increase) in inventories
2,648,000,000 JPY
17,262,000,000 JPY
Other
33,731,000,000 JPY
-12,683,000,000 JPY
Subtotal
270,335,000,000 JPY
242,693,000,000 JPY
Income taxes paid
-58,160,000,000 JPY
-33,834,000,000 JPY
Net cash provided by (used in) operating activities
212,174,000,000 JPY
208,859,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-25,193,000,000 JPY
-20,239,000,000 JPY
Purchase of intangible assets
-35,229,000,000 JPY
-38,937,000,000 JPY
Payments for acquisition of subsidiaries
JPY
-659,000,000 JPY
Other
-15,819,000,000 JPY
-13,142,000,000 JPY
Net cash provided by (used in) investing activities
-61,781,000,000 JPY
-47,586,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-10,555,000,000 JPY
-716,000,000 JPY
Other
-2,276,000,000 JPY
-1,840,000,000 JPY
Net cash provided by (used in) financing activities
-91,120,000,000 JPY
-141,264,000,000 JPY
Cash and cash equivalents
381,816,000,000 JPY
315,986,000,000 JPY
350,213,000,000 JPY
326,128,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
6,557,000,000 JPY
4,076,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.